[ad_1] La Food and Drug Administration (FDA) des États-Unis a approuvé une solution d'inhalation de revefenacin (YupelriTheravance Biopharma / Mylan) pour le traitement d'entretien des patients atteints de maladie pulmonaire obstructive chronique …
Read More »
[ad_1] LAFAYETTE, Ind. (WLFI) – The Federal Drug Administration has approved a new, very powerful opioid drug. Now, some who work closely with opioid addiction and overdoses have concerns. His name is …
Read More »
[ad_1] Copyright 2018 Nexstar Broadcasting, Inc. All Rights Reserved. This material may not be published, disseminated, rewritten or redistributed. TRENTON, N.J. (AP) – US regulators approved Friday a fast-acting, super-potent opioid tablet, …
Read More »
[ad_1] (Reuters) – An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approving Alkermes Plc’s treatment for depression in patients with an inadequate response to standard antidepressant …
Read More »
[ad_1] Jen Christensen, CNN (CNN) – The US Food and Drug Administration is alerting patients to another booster of the drug used to treat high blood pressure, pointing it to a potential …
Read More »
[ad_1] The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment. Genentech's drug Xofluza, which can be taken via a single oral dose to help patients recover more quickly …
Read More »
[ad_1] Our arsenal in the endless, roving, ever-evolving battle against the influenza virus just got slightly larger. The Food & Drug Administration just announced that they had approved the aptly-named Xofluza, the …
Read More »
[ad_1] (RNN) – La FDA envisage d’approuver une nouvelle forme de pilule d’un opioïde puissant que le président d’un comité consultatif qui a voté en faveur de son approbation a qualifié de …
Read More »
[ad_1] Credit: CC0 Public Domain The Food and Drug Administration wants to facilitate the sale of some common nonprescription drugs. The agency has proposed new guidelines Tuesday for drug manufacturers who want …
Read More »
[ad_1] SILVER SPRING, Md. – The United States Food and Drug Administration alerts health care professionals and patients of a voluntary recall of several drugs containing valsartan, an active ingredient used to …
Read More »